HKPD
Hong Kong Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HKPD Filings
Filing Date
Form Description
Form Type
2025-11-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-24 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-12
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-11-12 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-10-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-11
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-11 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-14
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-08-14 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-07-31
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-07-31 ·
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-06-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-06-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-06-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-06-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-06-03
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-06-03 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
